| P2093 | author name string | T. Meyer | |
| | C. Ulrich | |
| | W. Sterry | |
| | E. Stockfleth | |
| | T. Schmook | |
| | I. Nindl | |
| P2860 | cites work | Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug | Q29396548 |
| | The scientific basis of skin cancer | Q33801422 |
| | Imiquimod: a potential role in dermatology? | Q34722728 |
| | Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus | Q37320205 |
| | Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin | Q40384001 |
| | E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage | Q40896659 |
| | Comparative acute nephrotoxicity of salicylic acid, 2,3-dihydroxybenzoic acid, and 2,5-dihydroxybenzoic acid in young and middle aged Fischer 344 rats | Q41181254 |
| | The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence | Q42137289 |
| | Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients | Q42446627 |
| | High Frequency of Detection of Epidermodysplasia Verruciformis–Associated Human Papillomavirus DNA in Biopsies from Malignant and Premalignant Skin Lesions from Renal Transplant Recipients | Q42482331 |
| | Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. | Q42489905 |
| | Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia | Q42492863 |
| | Skin diseases following organ transplantation--risk factors and new therapeutic approaches | Q42501633 |
| | Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. | Q42522748 |
| | Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient | Q43586857 |
| | Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy | Q43666016 |
| | Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient | Q44097201 |
| | Treatment of genital warts with an immune-response modifier (imiquimod). | Q46023904 |
| | A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod | Q47713651 |
| | A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. | Q54090771 |
| | Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. | Q55067349 |
| | Human papillomavirus infections in a group of renal transplant recipients | Q70160345 |
| | Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients | Q70474673 |
| | A Potentially Oncogenic Human Papillomavirus (HPV-5) Found in Two Renal Allograft Recipients | Q72869049 |
| | Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients | Q73070683 |
| | Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum | Q73167338 |
| | Analysis of risk factors for cutaneous warts in renal transplant recipients | Q74060894 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Papillomaviridae | Q9055203 |
| | dermatology | Q171171 |
| P304 | page(s) | 20-24 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Viral warts in organ transplant recipients: new aspects in therapy | |
| P478 | volume | 149 Suppl 66 | |